Concepedia

Kei Takedomi

KT

Statistics

Publications

5

Citations

104

H-Index

5

Active since

2005

Affiliations

Tanabe Research Laboratories(Current)

Mitsubishi Tanabe Pharma Corporation

Kei Takedomi is an author at Tanabe Research Laboratories specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

2005–2019

5

Publications

5

Classification of Chemical Compounds by Protein−Compound Docking for Use in Designing a Focused Library

Yoshifumi Fukunishi, Yoshiaki Mikami, Kei Takedomi et al. · Journal of Medicinal Chemistry · 2005 · 41 citations · Full text

, , +14

Discovery of Novel Pyrazole-Based Selective Aldosterone Synthase (CYP11B2) Inhibitors: A New Template to Coordinate the Heme-Iron Motif of CYP11B2

Ryo Sakakibara, Wataru Sasaki, Yuichi Onda et al. · Journal of Medicinal Chemistry · 2018 · 21 citations · Full text

, , +17

Discovery of a pyrazolo[1,5-a]pyrimidine derivative (MT-3014) as a highly selective PDE10A inhibitor via core structure transformation from the stilbene moiety

Yuuki Koizumi, Yoshihito Tanaka, Takehiko Matsumura et al. · Bioorganic & Medicinal Chemistry · 2019 · 16 citations · Full text

, , +14

Combination of Virtual Screening and High Throughput Gene Profiling for Identification of Novel Liver X Receptor Modulators

Jie‐Fei Cheng, James Zapf, Kei Takedomi et al. · Journal of Medicinal Chemistry · 2008 · 14 citations

, , +17

Discovery and structure–activity relationship studies of indole derivatives as liver X receptor (LXR) agonists

Farid Bakir, Sunil M. Kher, Madhavi Pannala et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 12 citations · Full text

, , +14

1–5 of 5